DynamX®
Coronary Bioadaptor for PCI Procedures
The DynamX® bioadaptor is a drug-eluting coronary implant designed for percutaneous coronary intervention (PCI). Unlike conventional drug-eluting stents (DES), the DynamX® bioadaptor is designed to support the restoration of more physiological vessel function following vascular healing.
Following an initial phase of mechanical scaffolding and controlled drug elution, the DynamX® bioadaptor enters its bioadaptive phase. The unlocking of three helical strands is designed to restore vessel motion and support physiological hemodynamic modulation.
Bioadaptor is superior to DES for TLF at 4 years
In a 4-year follow-up analysis, the DynamX bioadaptor demonstrated a significantly lower TLF rate compared with DES (2.8% vs. 7.8%; p = 0.020).¹
Bioadaptor is superior to DES for cardiovascular death at 4 years
Four-year follow-up data showed a marked reduction in cardiac death with bioadaptor therapy (0.5% DynamX vs. 3.7% Onyx DES; p = 0.020).¹
Substantial benefit in LAD
Four-year data demonstrated substantial reduction in TLF with bioadaptor compared to DES (2.7% Dynamx vs 10.6% DES, p = 0.021).¹
Indications for Use
The DynamX® Bioadaptor is a permanent implant delivering Novolimus and is intended to improve coronary luminal diameter in patients with symptomatic ischemic heart disease.
LithiX™ HC-IVL
The HC-IVL balloon catheter (LithiX™) is indicated for the treatment of severely calcified coronary lesions in patients with coronary artery disease (CAD).
Learn moreProduct Overview
The table below provides key technical parameters at a glance. For complete sizing options and system details, please refer to the product flyer and Instructions for Use.
| Parameter | DynamX® |
|---|---|
| Product Type | Coronary Bioadaptor Stent System |
| Indication | Percutaneous Coronary Intervention (PCI) |
| Technology Concept | Dual-phase vessel behaviour |
| Clinical Evidence | Bioadaptor RCT & Infinity Swedeheart RCT |
Product Information and Instructions for Use
Technical Product Documentation
Includes detailed information on system design, clinical concept and available study data.
Open PDFRequest IFU & Clinical Documentation
For Instructions for Use or further clinical documentation, please use the contact form below.
Related Products for Complex Coronary Interventions
- EuroPCR 2026. BIOADAPTOR RCT 4-Year Clinical Outcomes (DynamX® vs DES), Late-breaking Trial Presentation, Paris. Elixir Medical, May 2026.
Sie haben Fragen zu diesem Produkt? Wir freuen uns auf Ihre Nachricht.
